Newsletter | June 16, 2026

06.16.26 -- The Editors' Roundtable: A Midyear Look At The 2026 Life Sciences Industry

SPONSOR

Bio-Expo Live Downstream Manufacturing Session is a virtual event for biopharma professionals focused on downstream manufacturing solutions. Attendees can discover new equipment and technologies supporting therapeutic areas from ADCs to vaccines through short, interactive presentations with live Q&A. The event is tailored for biopharma companies and contract manufacturers seeking solutions to overcome downstream manufacturing challenges. Register now to reserve your spot!

FOCUS ON OUTSOURCING

The Editors' Roundtable: A Midyear Look At The 2026 Life Sciences Industry

In this special edition of “Better Biopharma,” host Tyler Menichiello is joined by chief editors from across the Life Science Connect ecosystem to discuss what’s shaping the pharmaceutical industry in 2026. The editors reflect on recent developments in their respective spaces and make predictions on what the rest of the year has in store.

Understanding Nitrosamines: Key Regulations And Best Practices

Gain expert insights into nitrosamine regulations and discover practical strategies for ensuring compliance and safeguarding product safety.

Flexibility In Development: From Tactical Response To Strategic Imperative

Build flexibility into your drug development strategy to navigate change effectively, maintain momentum, and drive successful outcomes across every stage of the lifecycle.

Advancing Formulation Strategies For Complex Drug Products

An event-focused overview examining how formulation development and stability strategies support robust, scalable drug products discussed at the DDF Summit Berlin.

Optimized Transient Production: Faster Preclinical Studies With Enhanced QC

Accelerate your path from discovery to clinic by leveraging high-quality plasmid DNA, optimized expression systems, and early developability assessments to streamline transient protein production.

Strategic Hiring For Scalable Success

Discover how a people-first talent strategy, purpose-driven culture, and cross-functional collaboration come together to support scalable growth and operational excellence in commercial manufacturing.

A Smooth Transition To USP <382> With Established Expertise

A new regulatory chapter requires holistic, real‑world testing of injectable systems, mandating full‑system validation with actual drug products and prioritizing patient‑centric performance and safety.

USP <665> Compliance Guidance

Experts address key USP <665> questions, including risk assessment, testing approaches, extractables and leachable, and practical challenges in implementing single‑use systems in manufacturing.

OUTSOURCING SOLUTIONS

The Future Of Cell And Gene - AGC Biologics

iPSC Drug Discovery Platform - Applied StemCell

Developing A mAb For A Small Biotech Developing Precision Medicines - Lonza

Flexible Manufacturing From Development To Commercialization - Simtra BioPharma Solutions

A One-Stop Shop For All Your CRISPR Needs - Danaher Life Sciences

Next-Gen Modalities, Expertly Enabled - Syngene International Ltd.

Two Sites, One Standard Of Excellence - Jubilant HollisterStier

A Risk-Based Framework For Identity Testing - Andelyn Biosciences

Comprehensive Manufacturing Solutions Backed By Global Expertise - Novartis Contract Manufacturing

Connect With Bioprocess Online: